Natalie Rasgon, MD, PhD

Dr. Natalie Rasgon is a Professor in the Departments of Psychiatry and Behavioral Sciences, and Obstetrics and Gynecology at the Stanford University School of Medicine, the founder and director of the Stanford Center for Neuroscience in Women’s Health, and the co-founder of the Psychopathology and Allostatic load across the Life Span (PALS) Network. Dr. Rasgon is an internationally known thought leader and research in neuroscience in women’s mental health. Her lab also focuses on investigating the neuroscience of stress, specifically biomarkers of cellular aging in executives and gender differences in stress response. She has served as PI on more than 30 research studies and is a member of the board of directors of the National Network of Depression Centers (NNDC). She has edited two books on neuroendocrinology of diseases of the brain and is an executive co-editor for the Textbook on Mood Disorders to be published by the American Psychological Association. Dr. Rasgon has authored more than 230 scientific journal articles, chapters and abstracts. She has mentored 46 trainees and 34 junior faculty and has served on more than 30 PhD dissertation committees. She is a member of the editorial boards for 32 journals and is a graduate of the Executive Leadership in Academic Medicine program at Stanford. Additionally, Dr. Rasgon was selected as the recipient of the 2015 American Medical Women’s Association’s Lila Wallis Award for her contribution to women’s health.

Metabolic Psychiatry is a discipline that integrates the study and treatment of psychiatric illness and metabolic abnormalities. Metabolic abnormalities include conditions such as insulin resistance and pre-diabetes. In turn, these physical states are associated with cardiovascular disease, diabetes and premature brain aging. Years of research have shown a strong connection between these diseases and mental health disorders such as depression, bipolar illness, schizophrenia, eating and anxiety disorders. In addition, stress and trauma can lead to both metabolic and mental illnesses. I bring more than four decades of clinical and research experience in metabolic psychiatry at UCLA and Stanford University to offer comprehensive evaluations and a personalized medicine approach to the diagnosis and treatment of psychiatric conditions.